VectivBio Holding AG Financials

VectivBio Holding Stock Summary

VectivBio Holding competes with Cns Pharmaceuticals, ZyVersa Therapeutics, Immix Biopharma, Hepion Pharmaceuticals, and Enveric Biosciences. VectivBio Holding AG, a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for treatments of severe rare conditions. The company was incorporated in 2019 and is headquartered in Basel, Switzerland. VectivBio Holding is traded on NASDAQ Exchange in the United States.

VectivBio Holding Key Financial Ratios

VectivBio Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining VectivBio Holding's current stock value. Our valuation model uses many indicators to compare VectivBio Holding value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across VectivBio Holding competition to find correlations between indicators driving VectivBio Holding's intrinsic value. More Info.VectivBio Holding AG is rated third in return on equity category among its peers. It is rated fourth in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value VectivBio Holding by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

If you are still planning to invest in VectivBio Holding check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the VectivBio Holding's history and understand the potential risks before investing.